MNMD Insider Trading Activity and SEC Form 4 Filings
MNMD insider trading summary
No open-market insider purchases or sales of Mind Medicine (MindMed) Inc. (MNMD) have been reported on SEC Form 4 in the past 12 months.
Latest MNMD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 25, 2025 | Daniel Karlin | Chief Medical Officer | Sell | $75K (7,704 @ $9.77) |
| Sep 25, 2025 | Robert Barrow | Chief Executive Officer | Sell | $252K (25,797 @ $9.77) |
| Sep 25, 2025 | Mark Sullivan | Chief Legal Officer | Sell | $110K (11,278 @ $9.77) |
| Jun 25, 2025 | Robert Barrow | Chief Executive Officer | Sell | $180K (26,491 @ $6.80) |
| Jun 25, 2025 | Daniel Karlin | Chief Medical Officer | Sell | $53K (7,848 @ $6.80) |
| Jun 25, 2025 | Mark Sullivan | Chief Legal Officer | Sell | $78K (11,491 @ $6.80) |
| Mar 25, 2025 | Daniel Karlin | Chief Medical Officer | Sell | $46K (6,836 @ $6.74) |
| Mar 25, 2025 | Carrie Liao | Chief Accounting Officer | Sell | $16K (2,347 @ $6.74) |
| Mar 25, 2025 | Mark Sullivan | Chief Legal Officer | Sell | $44K (6,576 @ $6.74) |
| Mar 25, 2025 | Robert Barrow | Chief Executive Officer | Sell | $143K (21,208 @ $6.74) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.